He has had no recurrence for 4 years after surgery.
The patient remained alive without recurrence for 6 years.
Among these three patients, all four nuclear physicians concluded on recurrence for two patients, and only two nuclear physicians concluded on recurrence for the third patient.
Importantly, these biomarkers could significantly predict clinical recurrence for Gleason score 7 patients.
Patients in our case have survived without recurrence for 6 years after the surgery.
The patient has been doing well without any recurrence for 3 years.
To date, the patient has survived without tumor recurrence for more than 44 months following surgery.
At present, he is alive, without disease recurrence, for more than 44 months after his operation.
The patient has had no signs of recurrence for 6 months after the surgery.
Because of a short follow-up period, we cannot evaluate recurrence for this case.
All four patients are alive without recurrence for 2.7 to 7.1 years.
